Association of baseline lower respiratory tract microbiota composition and bacterial load with the risk of PD-1/PD-L1 inhibitor–associated immune-related pneumonitis: A single-center prospective cohort study
Acta Microbiologica et Immunologica Hungarica · 2026
DOI: 10.1556/030.2026.02909 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2026. Verfasst von Yun Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Oncology Department, The People's Hospital of Jiawang District of Xuzhou City, Xuzhou City, Jiangsu Province, China. Hauptthemen laut MEDLINE: Bacterial Load, Microbiota, Programmed Cell Death 1 Receptor, Pneumonia. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Immune checkpoint inhibitors improve outcomes in solid tumors, but immune-related pneumonitis (irP) can lead to treatment interruption and even death; current stratification mainly relies on medical history and imaging, lacking reproducible organ-specific biomarkers. This prospective cohort study evaluated the association of baseline lower respiratory tract microbiota features and bacterial load with the risk of PD-1/PD-L1-related irP. Bronchoalveolar lavage was performed before immunotherapy; 16S sequencing derived the Pathogen-Enrichment Score (PES), and quantitative PCR quantified total bacterial load. The primary endpoint was first occurrence of grade ≥2 irP within 6 months. Firth-corrected multivariable logistic regression adjusted for prior thoracic radiotherapy, baseline interstitial lung disease, and recent antibiotic use. Of 294 evaluable cases, 34 developed grades ≥2 irP. Baseline total bacterial load was significantly higher in patients who later developed irP, showing a monotonic dose-response relationship with risk (nonlinearity P = 0.183); adjusted odds ratio = 1.58 per 1 log 10 copies/mL ( P = 0.024). PES was also elevated (adjusted odds ratio = 1.43 per 1 SD, P = 0.033). The dysbiotic phenotype was characterized by reduced diversity and enrichment of Streptococcus , Veillonella , and Haemophilus , genera commonly associated with oral microbiota and aspiration. Adding PES and bacterial load to a clinical model improved discrimination (AUC 0.81 vs 0.73, P = 0.019) and reclassification (categorical NRI = 0.24, P = 0.004). Event rates across risk strata were 2.24, 13.46, and 32.65%. Baseline lower respiratory tract dysbiosis and elevated bacterial load indicate higher irP risk; adding these microbiologic measures to a clinical model improves prediction and risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Oncology Department, The People's Hospital of Jiawang District of Xuzhou City, Xuzhou City, Jiangsu Province, China.
- 2Radiation Therapy Department, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou City, Jiangsu Province, China.
- 3Oncology Department, The People's Hospital of Pizhou, Pizhou City, Jiangsu Province, China.
Zitieren
APA
Wang, Y., Wang, X., & Zhou, H. (2026). Association of baseline lower respiratory tract microbiota composition and bacterial load with the risk of PD-1/PD-L1 inhibitor–associated immune-related pneumonitis: A single-center prospective cohort study. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2026.02909
Vancouver
Wang Y, Wang X, Zhou H. Association of baseline lower respiratory tract microbiota composition and bacterial load with the risk of PD-1/PD-L1 inhibitor–associated immune-related pneumonitis: A single-center prospective cohort study. Acta Microbiologica et Immunologica Hungarica. 2026. doi:10.1556/030.2026.02909
BibTeX
@article{Wang2026,
author = {Wang, Yun and Wang, Xuefeng and Zhou, Henggen},
title = {Association of baseline lower respiratory tract microbiota composition and bacterial load with the risk of PD-1/PD-L1 inhibitor–associated immune-related pneumonitis: A single-center prospective cohort study},
journal = {Acta Microbiologica et Immunologica Hungarica},
year = {2026},
doi = {10.1556/030.2026.02909}
}
EUVIMED